Examine the ongoing battle over US drug prices and the potential effects of Trump’s recent pharma agreements on affordability. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Trump demands lower pharmaceutical prices from major drug companies in a bold move to align US costs with global standards. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...